VVP
NVO

Venture Visionary Partners’s Novo Nordisk NVO Stock Holding History

Venture Visionary Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
24,695
-6,552
-21% -$282K 0.03% 319
2026
Q1 		$1.15M Buy
31,247
+15,651
+100% +$742K 0.04% 301
2025
Q4 		$794K Buy
15,596
+10,864
+230% +$556K 0.03% 349
2025
Q3 		$263K Sell
4,732
-75,877
-94% -$4.44M 0.01% 531
2025
Q2 		$5.56M Buy
80,609
+19,110
+31% +$1.3M 0.21% 114
2025
Q1 		$4.27M Buy
61,499
+57,812
+1,568% +$4.77M 0.18% 126
2024
Q4 		$317K Sell
3,687
-2,200
-37% -$238K 0.01% 446
2024
Q3 		$701K Buy
5,887
+68
+1% +$9.07K 0.03% 320
2024
Q2 		$831K Buy
5,819
+1,901
+49% +$252K 0.04% 300
2024
Q1 		$503K Buy
3,918
+1,019
+35% +$121K 0.02% 377
2023
Q4 		$300K Buy
2,899
+19
+0.7% +$1.88K 0.02% 434
2023
Q3 		$262K Sell
2,880
-136
-5% -$12K 0.02% 436
2023
Q2 		$244K Sell
3,016
-86
-3% -$7.03K 0.01% 447
2023
Q1 		$247K Buy
3,102
+146
+5% +$10.4K 0.02% 437
2022
Q4 		$200K Buy
+2,956
New +$173K 0.01% 453
2022
Q3 		– Sell
-3,244
Closed -$181K – 1185
2022
Q2 		$181K Buy
+3,244
New +$180K 0.01% 466

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Venture Visionary Partners's NVO Position: Q2 2026 in Review

Venture Visionary Partners reduced its Novo Nordisk (NVO) stake by 21% in Q2 2026, selling an estimated $282K and leaving 24,695 shares worth $1.18M. The position accounts for 0.03% of the portfolio, ranked #319.

Venture Visionary Partners first reported a position in NVO in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.56M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Venture Visionary Partners held 24,695 shares of Novo Nordisk worth $1.18M as of Q2 2026.
  • Venture Visionary Partners sold 6,552 Novo Nordisk shares in Q2 2026, an estimated $282K.
  • Novo Nordisk made up 0.03% of Venture Visionary Partners's portfolio in Q2 2026, its #319 holding.
  • Venture Visionary Partners first reported a position in Novo Nordisk in Q2 2022 and has held it in 16 quarters since.
  • Venture Visionary Partners's Novo Nordisk position peaked at $5.56M in Q2 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.